The project

THE PROJECT MISSION

> The project ambitions

1

Increase structural knowledge and provide insights into performance and policies of screening vulnerable women.

2

Increase early detection and appropriate management of CCS in vulnerable women.

3

Create a flexible and responsive evaluation framework of co-constructed implementation models that predict the efficacy and effectiveness of tailored CCS programmes.

4

Reduce the burden of CC in the European Union, improve life expectancy and well-being, and reduce health inequities.

5

Decrease disease burden by more efficiently targeting vulnerable women and thus accelerate cervical cancer elimination.

> Missions

1

Assess current CCS status among vulnerable women, including existing policies, stakeholder landscape, barriers, and preferences for CCS among subgroup of vulnerable women (WP2, 3, 4). 

2

Develop tailored intervention models that increase CCS in subgroups of vulnerable women (WP2, 3).

3

Assess implementability and demonstrate scalability of intervention packages (WP6).

4

Assess health benefits and cost-effectiveness of intervention packages (WP5). 

5

Disseminate findings and deliver recommendations to EU representatives and policy makers, so they will translate into profound and long-lasting benefits for vulnerable women (WP7).

>THE CONCEPT

>THE PROJECT OBJECTIVES

OBJECTIVE 1

A defined CCS implementation strategy that will increase early detection and appropriate management of cervical cancer screening in vulnerable women, alleviating the global burden of disease.

OBJECTIVE 2

A map of existing screening policies focusing on vulnerable women.

OBJECTIVE 3

An evaluation framework of co-constructed implementation models that predict the contextual efficacy and effectiveness of tailored CCS programmes, including at the health systems level.

OBJECTIVE 4

Tailored CCS programmes that match vulnerable women’s needs and preference and can be adapted to national and regional levels.

OBJECTIVE 5

Recommendations for tailored CCS programmes to reach vulnerable women.

THE CONSORTIUM

Institut national de la santé et de la recherche médicale (Inserm)

Institut national de la santé et de la recherche médicale (Inserm)

Marc Bardou

Ecole d’économie de Paris (PSE)

Ecole d’économie de Paris (PSE)

Lise Rochaix

Inserm Transfert SA (IT)

Inserm Transfert SA (IT)

Christiane Dascher-Nadel

The International Agency for Research on Cancer (IARC)

The International Agency for Research on Cancer (IARC)

Partha Basu

CBIG-SCREEN, a 5-year collaborative research project, has received funding from the EU Horizon 2020 Research and Innovation Programme under Grant Agreement No 964049. Official starting date: 01. March 2021

Contact

  • Scientific Coordinator:
    Marc Bardou, Inserm
    E-mail
  • Project Manager:
    Christiane Dascher-Nadel, Inserm-Transfert
    E-mail

© CBIG-SCREEN Project 2021